Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection - ScienceDirect
Angiotensin Receptor Blockers versus ACE Inhibitors: Prevention of Death and Myocardial Infarction in High-Risk Populations - Benjamin J Epstein, John G Gums, 2005
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
CV Pharmacology | Angiotensin Converting Enzyme (ACE) Inhibitors
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension
Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review | European Respiratory Society
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
Frontiers | Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
New perspectives on angiotensin-converting enzyme 2 and its related diseases
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Angiotensin and the Coronavirus | Science | AAAS
Angiotensin-Converting Enzyme - Proteopedia, life in 3D
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition | PLOS ONE
Frontiers | Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
Frontiers | The Lung, the Heart, the Novel Coronavirus, and the Renin- Angiotensin System; The Need for Clinical Trials
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases | Pharmacological Reviews
ACE Inhibitor Pathway, Pharmacodynamics
COVID-19 and the Renin-Angiotensin System - Kidney International Reports
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
